Even brief UV exposure during dose drawing is fine
The proper, FDA-approved active pharmaceutical ingredient (API) is semaglutide base
JANUMET is contraindicated in patients with an estimated glomerular filtration rate (eGFR) below 30 mL/min/1.73 m2 [see Contraindications (4) and Warnings and Precautions (5.1)]
Includes EPA, DHA, and Other Omega-3s in triglyceride form (rTG+ TG)
While the science is still emerging, ongoing studies funded by the National Institute on Drug Abuse suggest significant potential across alcohol, stimulant, and compulsive behavior disorders
It is injected daily rather than weekly, has a shorter half-life (approximately 13 hours versus 7 days for semaglutide), and produces somewhat less weight loss